Tapp<strong>in</strong> DM, Greer K, Cameron S, Kennedy R, Brown AJ, Girdwood RW. Maternal antibody to<strong>hepatitis</strong> B core antigen detected <strong>in</strong> dried neonatal blood spot samples. Epidemiol Infect 1998;121:387-390.Tkeshelashvili-Kessler A, del Rio C, Nelson K, Tsertsvadze T. The emerg<strong>in</strong>g HIV/AIDS epidemic<strong>in</strong> Georgia. Int J STD AIDS 2005; 16:61-67.Torres JR. Hepatitis B <strong>and</strong> <strong>hepatitis</strong> delta <strong>virus</strong> <strong>in</strong>fection <strong>in</strong> South America. Gut 1996; 38(Suppl2):S48-S55.Tulisov A, Buz<strong>in</strong>ov R, Gordienko T. Incidence <strong>of</strong> viral <strong>hepatitis</strong> B <strong>and</strong> vacc<strong>in</strong>ation <strong>in</strong> theArkhangelsk region, Russian Federation. Int J Circumpolar Health 2004; 63(Suppl 2):205-208.Van Damme P, Van Herck K, Leuridan E, Vorsters A. Introduc<strong>in</strong>g universal <strong>hepatitis</strong> Bvacc<strong>in</strong>ation <strong>in</strong> Europe: differences still rema<strong>in</strong> between countries. Euro Surveill 2004; 8:47.Van Steenbergen JE, Baayen D, Peerbooms PG, Cout<strong>in</strong>ho RA, van den Hoek A. Much ga<strong>in</strong>ed by<strong>in</strong>tegrat<strong>in</strong>g contact trac<strong>in</strong>g <strong>and</strong> vacc<strong>in</strong>ation <strong>in</strong> the <strong>hepatitis</strong> B antenatal screen<strong>in</strong>g program <strong>in</strong>Amsterdam, 1992-1999. J Hepatol 2004; 40:979-985.Vasil'eva VI, Sumarokov AA, Kozhevnikova LK, Asratian AA, Gorbunov MA. Frequency <strong>of</strong>f<strong>in</strong>d<strong>in</strong>g <strong>hepatitis</strong> B viral markers <strong>in</strong> young children born <strong>of</strong> mothers carry<strong>in</strong>g the HBs-antigen. ZhMikrobiol Epidemiol Immunobiol 1987; 2:32-35. [Article <strong>in</strong> Russian]Vorozhbieva TE, Ias<strong>in</strong>skii AV, Alieva G, Mikhailov MI, Iavorkovskaia EK. Characteristics <strong>of</strong> thedistribution <strong>of</strong> the markers <strong>of</strong> <strong>hepatitis</strong> B vir us <strong>in</strong>fection among the healthy population <strong>of</strong> theTadzhik SSR <strong>and</strong> Azerbaijan SSR. Zh Mikrobiol Epidemiol Immunobiol 1985; 10:35-39. [Article<strong>in</strong> Russian]Wang JS, Zhu QR, Wang XH. Breastfeed<strong>in</strong>g does not pose any additional risk <strong>of</strong>immunoprophylaxis failure on <strong>in</strong>fants <strong>of</strong> HBV carrier mothers. Int J Cl<strong>in</strong> Pract 2003; 57:100-102.Williams A. Reduction <strong>in</strong> the <strong>hepatitis</strong> B related burden <strong>of</strong> disease--measur<strong>in</strong>g the success <strong>of</strong>universal immunisation programs. Commun Dis Intell 2002; 6:458-40.Xu ZY, Duan SC, Margolis HS, Purcell RH, Ou-Yang PY, Coleman PJ, Zhuang YL, Xu HF, QianSG, Zhu QR, et al. Long-term efficacy <strong>of</strong> active postexposure immunization <strong>of</strong> <strong>in</strong>fants forprevention <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong> <strong>in</strong>fection. United States - People's Republic <strong>of</strong> Ch<strong>in</strong>a StudyGroup on Hepatitis B. J Infect Dis 1995; 171:54-60.Yue Y, Meng J, Zhang S. Mechanism <strong>of</strong> peripheral blood mononuclear cell <strong>in</strong>vasion by HBV onartificial immunization <strong>in</strong> newborns. Ch<strong>in</strong> Med J (Engl) 2002; 115:1380-1382.Zanetti AR. Maternal-neonatal <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong>. Epidemiology <strong>and</strong> prevention.Ann Ist Super Sanità 1987; 24:277-284.Zanetti AR, Dentico P, Del Vecchio Blanco C, Sagnelli E, Villa E, Ferroni P, Bergam<strong>in</strong>i F.Multicenter trial on the efficacy <strong>of</strong> HBIG <strong>and</strong> vacc<strong>in</strong>e <strong>in</strong> prevent<strong>in</strong>g <strong>per<strong>in</strong>atal</strong> <strong>hepatitis</strong> B. F<strong>in</strong>alreport. J Med Virol 1986; 18:327-334.Zanetti AR, Ferroni P, Magliano EM, Pirovano P, Lavar<strong>in</strong>i C, Massaro AL, Gav<strong>in</strong>elli R, Fabris C,Rizzetto M. Per<strong>in</strong>atal <strong>transmission</strong> <strong>of</strong> the <strong>hepatitis</strong> B <strong>virus</strong> <strong>and</strong> <strong>of</strong> the HBV-associated delta agentfrom mothers to <strong>of</strong>fspr<strong>in</strong>g <strong>in</strong> northern Italy. J Med Virol 1982; 9:139-148.Zanetti AR, Ferroni P, Tanzi E, Bergam<strong>in</strong>i F. Screen<strong>in</strong>g <strong>of</strong> pregnant women <strong>and</strong> <strong>hepatitis</strong> Bprophylaxis <strong>in</strong> newborns. J Virol Methods 1985; 10:341-347.Zanetti AR, Magliano EM, Tanzi E, Ferroni P, Pirovano G, Pizzocolo G, Pillan N, Zun<strong>in</strong> C. HBIGimmunoprophylaxis <strong>of</strong> babies born to HBsAg carrier mothers. Dev Biol St<strong>and</strong> 1983; 54:383-389.Zanetti AR, Tanzi E, Newell ML. Mother-to-<strong>in</strong>fant <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> C <strong>virus</strong>. J Hepatol1999; 31(Suppl 1):96-100.Zanetti AR, Tanzi E, Paccagn<strong>in</strong>i S, Pr<strong>in</strong>cipi N, Pizzocolo G, Caccamo ML, D'Amico E, Cambie G,Vecchi L, <strong>and</strong> the Lombardy Study Group on Vertical HCV Transmission. Mother-to-<strong>in</strong>fant<strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> C <strong>virus</strong>. Lancet 1995; 345:289-291.Zanetti AR, Tanzi E, Romanò L, Pr<strong>in</strong>cipi N, Zu<strong>in</strong> G, M<strong>in</strong>ola E, Zapparoli B, Palmieri M, Mar<strong>in</strong>iA, Ghisotti D, Friedman P, Hunt J, Laffler T, <strong>and</strong> the Lombardy Study Group onVertical/Per<strong>in</strong>atal Hepatitis Viruses Transmission. Multicenter trial on mother-to-<strong>in</strong>fant<strong>transmission</strong> <strong>of</strong> GBV-C <strong>virus</strong>. J Med Virol 1998; 54:107-112.Zanetti AR, Tanzi E, Romanò L, Zu<strong>in</strong> G, M<strong>in</strong>ola E, Vecchi L, Pr<strong>in</strong>cipi N. A prospective study onmother-to-<strong>in</strong>fant <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> C <strong>virus</strong>. Intervirology 1998; 41:208-212.56
Zanetti A, Tanzi E, Sempr<strong>in</strong>i AE. Hepattis C <strong>in</strong>fection <strong>in</strong> pregnancy <strong>and</strong> risk <strong>of</strong> vertical<strong>transmission</strong>. Ref Gynecol Obstet 2001; 8:257-260.Zhavoronok SV. Detection rate <strong>of</strong> antibodies aga<strong>in</strong>st delta <strong>virus</strong> among HBsAg carriers <strong>in</strong> a regionwith moderate prevalence <strong>of</strong> <strong>hepatitis</strong> B. Vopr Virusol 1989; 34:675-679. [Article <strong>in</strong> Russian]Zhong M, Hou J, Luo K. Identification <strong>of</strong> vertical <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong> from mother tochildren by direct sequenc<strong>in</strong>g a segment <strong>of</strong> surface gene <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong>. Zhonghua Yi XueZa Zhi 1996; 76:194-196. [Article <strong>in</strong> Ch<strong>in</strong>ese]Zu<strong>in</strong> G, Saccani B, Di Giacomo S, Tanzi E, Zanetti AR, Pr<strong>in</strong>cipi N. Outcome <strong>of</strong> mother to <strong>in</strong>fantacquired GBV-C/HGV <strong>in</strong>fection. Arch Dis Child Fetal Neonatal Ed 1999; 80:F72-F73.57
- Page 1 and 2:
Pre-meeting documentPrevention and
- Page 3 and 4:
Part I Prevention and control of pe
- Page 5 and 6: prevalence was significantly higher
- Page 7 and 8: clusters (obstetrics wards/hospital
- Page 9 and 10: Boxall E. Screening of pregnant wom
- Page 11 and 12: Chang MH, Hsu HY, Huang LM, Lee PI,
- Page 13 and 14: of infection in infants and childre
- Page 15 and 16: Eriksen EM, Perlman JA, Miller A, M
- Page 17 and 18: liver enzyme abnormalities than wer
- Page 19 and 20: health care, is feasible and achiev
- Page 21 and 22: HBsAg and anti-HBs in 4.5%. In the
- Page 23 and 24: immunoprophylaxis. Reflecting effec
- Page 25 and 26: Levin CE, Nelson CM, Widjaya A, Mon
- Page 27 and 28: Delaying vaccination of premature i
- Page 29 and 30: diagnosis. In the past, the inciden
- Page 31 and 32: shows that the prevalence of HBV in
- Page 33 and 34: Niu MT, Targonski PV, Stoll BJ, Alb
- Page 35 and 36: Ranger-Rogez S, Alain S, Denis F. H
- Page 37 and 38: vaccinees) and low reactogenicity o
- Page 39 and 40: single ELISA test is about Rs40. At
- Page 41 and 42: newborns with surface antigenemia,
- Page 43 and 44: Wang Z, Zhang J, Yang H, Li X, Wen
- Page 45 and 46: of hepatitis B vaccine. This study
- Page 47 and 48: transmission has been estimated at
- Page 49 and 50: at birth and 2 weeks after birth, f
- Page 51 and 52: Chubinishvili OV, Mikhailov MI, Sak
- Page 53 and 54: Jensen L, Heilmann C, Smith E, Want
- Page 55: Onishchenko GG. Incidence of infect
Change language